Abstract
Prostate cancer (PCA) is the most common malignancy in men in USA, and the role of Trichomonas vaginalis (T. vag) in the development of PCA is still controversial. Clonogenic assay, PCNA staining, TUNEL staining and caspase-3 activity assay were used to investigate the in vitro role of T. vag in human prostate cancer. We further investigated the possible molecular mechanisms using RT-PCR and immunohistochemical staining. Culture supernatant of T. vag inhibits growth of PC-3 prostate cancer cells, and this correlated with upregulation of p21. Culture supernatant of T. vag induced apoptosis of PC-3 cells, and this correlated with downregulation of Bcl-2. The growth inhibition effect of culture supernatant of T. vag is also demonstrated in another prostate cancer cell line DU145, suggesting that its effect is not specific to one prostate cancer cell line. Culture supernatant of T. vag inhibits growth of prostate cancer by inhibition of proliferation and promotion of apoptosis. Such a study might be helpful to address the association between PCA and infection of T. vag.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: Cancer J Clin. 2015;65(1):5–29.
Crawford ED. Epidemiology of prostate cancer. Urology. 2003;62(6):3–12.
Dirkx M, Boyer MP, Pradhan P, Brittingham A, Wilson WA. Expression and characterization of a beta-fructofuranosidase from the parasitic protist Trichomonas vaginalis. BMC Biochem. 2014;15(1):12.
Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev. 1998;11(2):300–17.
Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MCB, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40(3):187–93.
Workowski KA, Berman SM. Centers for disease control and prevention sexually transmitted disease treatment guidelines. Clin Infect Dis. 2011;53(Suppl 3):S59–63.
Wynder EL, Mabuchi K, Whitmore WF. Epidemiology of cancer of the prostate. Cancer. 1971;28(2):344–60.
Harkness A. Discussion on non-specific prostatitis. Proc Royal Soc Med. 1955;48(5):413–24.
Perl G, Schapira H, Ragazzoni H. Male urogenital trichomoniasis. J Mount Sinai Hospital, New York. 1965;32:495.
Gardner Jr WA, Culberson DE. Pathology of urogenital trichomoniasis in men. In: Trichomonads parasitic in humans. New York: Springer; 1990, p. 291–6.
Smith C, Gardner W Jr. Inflammation-proliferation: possible relationships in the prostate. Prog Clin Biol Res. 1986;239:317–25.
Twu O, Dessí D, Vu A, Mercer F, Stevens GC, De Miguel N, et al. Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses. Proc Natl Acad Sci. 2014;111(22):8179–84.
Caini S, Gandini S, Dudas M, Bremer V, Severi E, Gherasim A. Sexually transmitted infections and prostate cancer risk: a systematic review and meta-analysis. Cancer Epidemiol. 2014;38(4):329–38. doi:10.1016/j.canep.2014.06.002.
Donders GG, Depuydt CE, Bogers J-P, Vereecken AJ. Association of Trichomonas vaginalis and cytological abnormalities of the cervix in low risk women. PLoS One. 2013;8(12):e86266.
Groom H, Warren AY, Neal DE, Bishop KN. No evidence for infection of UK prostate cancer patients with XMRV, BK virus, Trichomonas vaginalis or human papilloma viruses. PLoS One. 2012;7(3):e34221.
Alderete J, Pearlman E. Pathogenic Trichomonas vaginalis cytotoxicity to cell culture monolayers. Br J Vener Dis. 1984;60(2):99–105.
Gilbert R, Elia G, Beach D, Klaessig S, Singh B. Cytopathogenic effect of Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro. Infect Immun. 2000;68(7):4200–6.
Guenthner PC, Secor WE, Dezzutti CS. Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1. Infect Immun. 2005;73(7):4155–60.
Rasmussen S, Nielsen M, Lind I, Rhodes J. Morphological studies of the cytotoxicity of Trichomonas vaginalis to normal human vaginal epithelial cells in vitro. Genitourin Med. 1986;62(4):240–6.
Rendón-Maldonado JG, Espinosa-Cantellano M, González-Robles A, Martinez-Palomo A. Trichomonas vaginalis: in vitrophagocytosis of lactobacilli, vaginal epithelial cells, leukocytes, and erythrocytes. Exp Parasitol. 1998;89(2):241–50.
Quan J-H, Kang B-H, Cha G-H, Zhou W, Koh Y-B, Yang J-B, et al. Trichonomas vaginalis metalloproteinase induces apoptosis of SiHa cells through disrupting the Mcl-1/Bim and Bcl-xL/Bim complexes. PLoS one. 2014;9(10):e110659.
Salvador-Membreve DMC, Jacinto SD, Rivera WL. Trichomonas vaginalis induces cytopathic effect on human lung alveolar basal carcinoma epithelial cell line A549. Exp Parasitol. 2014;147:33–40.
Beal C, Goldsmith R, Kotby M, Sherif M, El-Tagi A, Farid A, et al. The plastic envelope method, a simplified technique for culture diagnosis of trichomoniasis. J Clin Microbiol. 1992;30(9):2265–8.
Nielsen TJ, Pradhan P, Brittingham A, Wilson WA. Glycogen accumulation and degradation by the trichomonads Trichomonas vaginalis and Trichomonas tenax. J Eukaryot Microbiol. 2012;59(4):359–66.
Tan S, Singh M, Yap E, Ho L, Moe K, Howe J, et al. Colony formation of Blastocystis hominis in soft agar. Parasitol Res. 1996;82(4):375–7.
Fang Y, Bradley MJ, Cook KM, Herrick EJ, Nicholl MB. A potential role for resveratrol as a radiation sensitizer for melanoma treatment. J Surg Res. 2013;183(2):645–53.
Fang Y, DeMarco VG, Nicholl MB. Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci. 2012;103(6):1090–8.
Fang Y, Herrick EJ, Nicholl MB. A possible role for perforin and granzyme B in resveratrol-enhanced radiosensitivity of prostate cancer. J Androl. 2012;33(4):752–60.
Fang Y, Moore BJ, Bai Q, Cook KM, Herrick EJ, Nicholl MB. Hydrogen peroxide enhances radiation-induced apoptosis and inhibition of melanoma cell proliferation. Anticancer Res. 2013;33(5):1799–807.
Fang Y, Sharp GC, Yagita H, Braley-Mullen H. A critical role for TRAIL in resolution of granulomatous experimental autoimmune thyroiditis. J Pathol. 2008;216(4):505–13.
Fang Y, Wei Y, DeMarco V, Chen K, Sharp GC, Braley-Mullen H. Murine FLIP transgene expressed on thyroid epithelial cells promotes resolution of granulomatous experimental autoimmune thyroiditis in DBA/1 mice. Am J Pathol. 2007;170(3):875–87.
Johnson D, Walker C. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol. 1999;39(1):295–312.
Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol. 1995;15(5):2612–24.
Sherr CJ. G1 phase progression: cycling on cue. Cell. 1994;79(4):551–5.
Sherr CJ. D-type cyclins. Trends Biochem Sci. 1995;20(5):187–90.
Fang Y, Chen X, Bai Q, Qin C, Mohamud AO, Zhu Z, et al. IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL. J Surg Oncol. 2015;111(8):969–74.
Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270(5239):1189–92.
Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267(5203):1456.
Fang Y, Braley-Mullen H. Cultured murine thyroid epithelial cells expressing transgenic Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein are protected from Fas-mediated apoptosis. Endocrinology. 2008;149(7):3321–9.
Nicholl MB, Ledgewood CL, Chen X, Bai Q, Qin C, Cook KM, et al. Il-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: evidence for a role as an autocrine growth factor. Cytokine. 2014;70(2):126–33.
Acknowledgments
This study was supported by grants from Des Moines University for Yujiang Fang, M.D. Ph.D. (Iowa Science Foundation Grant ISF 16-8, IOER 05-14-01 and IOER 112-3749). Kristoffer T. Davidson was supported by Mentored Research Program from Des Moines University (IOER 112-3113).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Zhu, Z., Davidson, K.T., Brittingham, A. et al. Trichomonas vaginalis: a possible foe to prostate cancer. Med Oncol 33, 115 (2016). https://doi.org/10.1007/s12032-016-0832-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-016-0832-y